Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis
Michiko Itoh, … , Masato Tanaka, Yoshihiro Ogawa
Michiko Itoh, … , Masato Tanaka, Yoshihiro Ogawa
Published November 16, 2017
Citation Information: JCI Insight. 2017;2(22):e92902. https://doi.org/10.1172/jci.insight.92902.
View: Text | PDF
Research Article Hepatology Inflammation

CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis

  • Text
  • PDF
Abstract

Although recent evidence has pointed to the role of organ- and pathogenesis-specific macrophage subsets, it is still unclear which subsets are critically involved in the pathogenesis of nonalcoholic steatohepatitis (NASH). Using melanocortin-4 receptor–deficient (MC4R-KO) mice fed Western diet (WD), which exhibit liver phenotypes similar to those of human NASH, we found a histological structure, termed hepatic crown-like structure (hCLS), in which CD11c+ macrophages surround dead/dying hepatocytes, a prominent feature of NASH. Here, we demonstrate that hCLS-constituting macrophages could be a novel macrophage subset that drives hepatocyte death-triggered liver fibrosis. In an “inducible NASH model,” hepatocyte death induces hCLS formation and liver fibrosis sequentially in the short term. In combination with the long-term WD feeding model, we also showed that resident macrophages are a major cellular source of CD11c+ macrophages constituting hCLS, which exhibited gene expression profiles distinct from CD11c– macrophages scattered in the liver. Moreover, depletion of CD11c+ macrophages abolished hCLS formation and fibrogenesis in NASH. Our clinical data suggest the role of CD11c+ macrophages in the disease progression from simple steatosis to NASH. This study sheds light on the role of resident macrophages, in addition to recruited macrophages, in the pathogenesis of NASH.

Authors

Michiko Itoh, Takayoshi Suganami, Hideaki Kato, Sayaka Kanai, Ibuki Shirakawa, Takeru Sakai, Toshihiro Goto, Masahiro Asakawa, Isao Hidaka, Hiroshi Sakugawa, Koji Ohnishi, Yoshihiro Komohara, Kenichi Asano, Isao Sakaida, Masato Tanaka, Yoshihiro Ogawa

×

Figure 2

Establishment of an inducible NASH model.

Options: View larger image (or click on image) Download as PowerPoint
Establishment of an inducible NASH model.
(A) Experimental protocol of t...
(A) Experimental protocol of the inducible NASH model using MC4R-KO mice. Eight-week-old MC4R-KO mice were fed WD for 4 weeks and received a single injection of CCl4 at a dose of 0.1 ml/kg (diluted 1:40 in olive oil) or olive oil as vehicle (Veh) intraperitoneally. (B) Serum ALT concentrations after CCl4 injection. (C) Hematoxylin and eosin staining, (D) cytokeratin 18 immunostaining, and (E) Sirius red staining of the liver at each time point after the low-dose CCl4 injection. Arrows, ballooning degeneration of hepatocytes. CV, central veins. Scale bar: 50 μm. (F) Time course of hepatic mRNA expression of genes related to inflammation (Tnfa and Itgax) and fibrogenesis (Tgfb1 and Col1a1). Data represent mean ± SEM. *P < 0.05, **P < 0.01 vs. Veh (day 7), #P < 0.05, ##P < 0.01 (Tukey-Kramer test). n = 7–15.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts